Hill's Is Making Two Big Bets on the Future of Pet Food. One Is About the Farm. One Is About the Lab.

Hill's Pet Nutrition made two announcements this week that, taken together, say a lot about where the pet food industry is heading. One looks at how ingredients are grown. The other looks at how they are made. Both are worth paying attention to.

The farm side: a regenerative agriculture partnership with ADM

Hill's has announced a new partnership with ADM to advance regenerative agriculture practices across North America and EMEA, with an initial focus on farming operations in Illinois, Minnesota, and Hungary. The collaboration is designed to accelerate adoption of sustainable farming methods by offering financial incentives and direct support to farmers making the shift.

Regenerative agriculture is not a new concept, but it has been slow to scale in the ingredient supply chains that feed the pet food industry. This partnership is an attempt to move that needle by attaching real economic support to the ask. For farmers, that matters. Changing how you farm is a financial risk, and programs that share that risk tend to move faster than ones that simply encourage the behavior.

For veterinary professionals, this is worth tracking because the long-term health implications of soil health, ingredient quality, and supply chain sustainability are starting to show up in the research. Where food comes from is becoming as relevant a clinical conversation as what is in it.

The lab side: an FDA milestone for a new kind of protein

The second announcement is more immediately significant for the profession. Hill's and Bond Pet Foods have confirmed that the FDA Center for Veterinary Medicine has issued a Letter of No Objection for Bond's Lamb Protein Yeast ingredient, a novel protein source produced through precision fermentation. This is a meaningful regulatory milestone. A Letter of No Objection from CVM signals that the agency has reviewed the ingredient and has no safety objections to its use in animal food, clearing the path toward commercial use.

Precision fermentation works by programming yeast or other microorganisms to produce specific proteins that are biologically identical to those found in conventional animal sources, without requiring the animal. The result is a high-quality protein that proponents argue is more sustainable, more consistent, and more ethically produced than traditional methods.

For clinicians, the practical question will eventually become how these novel proteins perform in patients with food sensitivities, allergies, or specific dietary needs, and whether the fermentation-derived profile behaves the same way in the body as the conventionally sourced equivalent. That research will take time, but the regulatory door is now open.

The pet food landscape is changing faster than most practices realize. These two announcements, one rooted in soil and one rooted in science, are a signal of what that change looks like from the inside.